Plasma apolipoproteins A1/B and oxLDL levels in patients with COVID-19 as possible markers of the disease
Saved in:
| Date: | 2021 |
|---|---|
| Main Authors: | V. V. Pushkarov, L. K. Sokolova, S. A. Cherviakova, Yu. B. Belchyna, O. I. Kovzun, V. M. Pushkarov, M. D. Tronko |
| Format: | Article |
| Language: | English |
| Published: |
2021
|
| Series: | Cytology and genetics |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001302356 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Determination of groups of risks at the diseases COVID-19
by: A. A. Vagis, et al.
Published: (2021)
by: A. A. Vagis, et al.
Published: (2021)
Determination of Groups of Risks at the Diseases COVID-19
by: O. A. Vahis, et al.
Published: (2020)
by: O. A. Vahis, et al.
Published: (2020)
COVID-19 infection: disease mechanism, vascular dysfunction, immune responses, markers, multiorgan failure, treatments, and vaccination
by: S. G. Vari
Published: (2020)
by: S. G. Vari
Published: (2020)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
MARK activation in human blood mononuclear cells in types 1 and 2 diabetes
by: V. V. Pushkarov, et al.
Published: (2020)
by: V. V. Pushkarov, et al.
Published: (2020)
Clinic and complications of COVID-19 coronavirus disease with pathogenesis elements
by: V. P. Malyi, et al.
Published: (2020)
by: V. P. Malyi, et al.
Published: (2020)
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)
by: M. D. Tronko, et al.
Published: (2022)
COVID-19: New disease and chaos with panic, associated with stres
by: S. Szabo
Published: (2020)
by: S. Szabo
Published: (2020)
The role of endoplasmic reticulum stress and NLRP3-inflammasomes in the development of atherosclerosis
by: V. V. Pushkarov, et al.
Published: (2021)
by: V. V. Pushkarov, et al.
Published: (2021)
Evaluation of Interleukins and Biochemical Markers Levels Among COVID-19 Iraqi Patients
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)
by: Al-Jubury, Kutaiba Sattar, et al.
Published: (2025)
Determination of the dependence between climatic factors and Covid-19 disease incidence
by: Mitryasova, Olena P., et al.
Published: (2021)
by: Mitryasova, Olena P., et al.
Published: (2021)
Determination of the dependence between climatic factors and Covid-19 disease incidence
by: O. P. Mitriasova, et al.
Published: (2021)
by: O. P. Mitriasova, et al.
Published: (2021)
Study of the coronavirus SARS-CoV-2 and the COVID-19 disease caused by it
by: S. V. Komisarenko
Published: (2021)
by: S. V. Komisarenko
Published: (2021)
Effects of paclitaxel and nuclear factor NF-кB inhibitor in thyroid cancer tumors in vivo
by: V. M. Pushkarov, et al.
Published: (2014)
by: V. M. Pushkarov, et al.
Published: (2014)
Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
The coronavirus disease COVID-19's coverage in Ukrainian and European encyclopedias
by: M. H. Zhelezniak, et al.
Published: (2020)
by: M. H. Zhelezniak, et al.
Published: (2020)
The virtual screening application for searching potential antiviral agents to treat COVID-19 disease
by: L. V. Yevsieieva, et al.
Published: (2020)
by: L. V. Yevsieieva, et al.
Published: (2020)
Immunoglobulin isotypes and blood monocyte subpopulations in COVID-19 female patients with different disease severity
by: K. Rebenko, et al.
Published: (2022)
by: K. Rebenko, et al.
Published: (2022)
Paclitaxel action on thyroid anaplastic cancer cell line KTC-3 stable to drug
by: V. V. Pushkarov, et al.
Published: (2012)
by: V. V. Pushkarov, et al.
Published: (2012)
Treatment of systemic diseases of connective tissue during the COVID-19 pandemic: literature review and own investigation
by: L. S. Kholopov, et al.
Published: (2020)
by: L. S. Kholopov, et al.
Published: (2020)
About the problem of preventing the spread of COVID-19 coronavirus disease among children and adolescents of school age
by: O. V. Bobrova, et al.
Published: (2022)
by: O. V. Bobrova, et al.
Published: (2022)
A hybrid convolutional network for image processing x-ray images for detection of the disease of COVID-19
by: Ye. M. Fedorchenko, et al.
Published: (2022)
by: Ye. M. Fedorchenko, et al.
Published: (2022)
Covid-19 as the new social reality
by: V. Stepanenko
Published: (2020)
by: V. Stepanenko
Published: (2020)
Covid-19 as the new social reality
by: V. Stepanenko
Published: (2020)
by: V. Stepanenko
Published: (2020)
COVID-19 pandemic and fiscal sustainability
by: O. V. Stepanova
Published: (2020)
by: O. V. Stepanova
Published: (2020)
Cerebrovascular disorders in patients with COVID-19
by: Yu. V. Shmatko, et al.
Published: (2021)
by: Yu. V. Shmatko, et al.
Published: (2021)
Determinants of Consumer Behaviour in the COVID-19 Pandemic
by: N. V. Mykytenko, et al.
Published: (2021)
by: N. V. Mykytenko, et al.
Published: (2021)
Handbook of COVID-19 prevention and treatme
by: N. Matolinets
Published: (2020)
by: N. Matolinets
Published: (2020)
Use of Information Technology in Countering COVID-19
by: O. V. Tymoshenko, et al.
Published: (2020)
by: O. V. Tymoshenko, et al.
Published: (2020)
Socio-economic outcomes of the COVID-19 pandemic for Ukraine
by: V. Butkaljuk
Published: (2021)
by: V. Butkaljuk
Published: (2021)
Socio-economic outcomes of the COVID-19 pandemic for Ukraine
by: V. Butkaliuk
Published: (2021)
by: V. Butkaliuk
Published: (2021)
The Impact of COVID-19 on the World's Economies
by: D. V. Dolbnieva
Published: (2020)
by: D. V. Dolbnieva
Published: (2020)
Peculiarities of Libraries’ Activities during COVID-19
by: D. Voloshyn
Published: (2024)
by: D. Voloshyn
Published: (2024)
Recent phraseological coinages of the COVID-19 period
by: N. S. Khoroz
Published: (2021)
by: N. S. Khoroz
Published: (2021)
Similar Items
-
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021) -
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021) -
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021) -
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)